doi: 10.1016/S2468-1253(21)00020-0 111 BajajHSBurrowsMBlavignacJParonECamachoFGouldEet al
Dwa formaty tego samego compound, dobrane pod rne potrzeby badawcze
No product or service offered by the Company through its Website is intended to offer any medical advice, suggestion, diagnosis, cure, or relief for any medical issue whatsoever and is sold on the single premise of research only
Injection site reactions (erythema, pruritus, swelling) occur in 1.4-2.4% of patients using subcutaneous formulations and are well-documented, localized effects
Various chemical modifications, formulation techniques, and innovative approaches are being explored in an attempt to alleviate these limitations
Oxygen-sensitive mitochondrial accumulation of cystathionine beta-synthase mediated by Lon protease